UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

N -Acetyl-l-Leucine-Polyethyleneimine-Mediated Delivery of CpG Oligodeoxynucleotides 2006 Inhibits RAW264.7 Cell Osteoclastogenesis

Drug design, development and therapy, 2020-01, Vol.14, p.2657-2665

2020

Volltextzugriff (PDF)

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

Cancers, 2021-08, Vol.13 (16), p.4081

2021

Volltextzugriff (PDF)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice

Iranian journal of basic medical sciences, 2021-03, Vol.24 (3), p.377-382

2021

Volltextzugriff (PDF)

Expression of the transcribed ultraconserved region 70 and the related long non‐coding RNA AC092652.2‐202 has prognostic value in Chronic Lymphocytic Leukaemia

British journal of haematology, 2019-03, Vol.184 (6), p.1045-1050

2019

Volltextzugriff (PDF)

LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice

Virologica Sinica, 2022-10, Vol.37 (5), p.731-739

2022

Volltextzugriff (PDF)

Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections

Frontiers in immunology, 2016-07, Vol.7, p.284-284

2016

Volltextzugriff (PDF)

Phase I Trial of Wilms' Tumor 1 (WT1) Peptide Vaccine with GM-CSF or CpG in Patients with Solid Malignancy

Anticancer research, 2012-06, Vol.32 (6), p.2263-2269

2012

Volltextzugriff (PDF)

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine

Pharmaceutics, 2022-04, Vol.14 (5), p.973

2022

Volltextzugriff (PDF)

Oral priming with oligodeoxynucleotide particles from Lactobacillus rhamnosus GG attenuates symptoms of dextran sodium sulfate‐induced acute colitis in mice

Animal science journal, 2020-01, Vol.91 (1), p.e13468-n/a

2020

Volltextzugriff (PDF)

Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate

Vaccine, 2012-12, Vol.30 (52), p.7498-7505

2012

Volltextzugriff (PDF)

Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides

Immunology, 2007-03, Vol.120 (3), p.412-423

2007

Volltextzugriff (PDF)

IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN

Immunology and cell biology, 2011-10, Vol.89 (7), p.777-785

2011

Volltextzugriff (PDF)

Transcriptome and microRNAome elucidate the mechanism underlying the immunomodulatory effects of dietary CpG oligodeoxynucleotides (CpG ODNs) in Litopenaeus vannamei

Aquaculture, 2024-12, Vol.593, p.741275, Article 741275

2024

Volltextzugriff (PDF)

Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN

Cellular immunology, 2013-07, Vol.284 (1-2), p.98-103

2013

Volltextzugriff (PDF)

Vascular bursts-mediated tumor accumulation and deep penetration of spherical nucleic acids for synergistic radio-immunotherapy

Journal of controlled release, 2022-08, Vol.348, p.1050-1065

2022

Volltextzugriff (PDF)

Nanoscale Zeolitic Imidazolate Framework‑8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides

ACS applied materials & interfaces, 2017-09, Vol.9 (37), p.31519-31525

2017

Volltextzugriff (PDF)

An effective dendritic cell‐based vaccine containing glioma stem‐like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma

International journal of cancer, 2019-06, Vol.144 (11), p.2867-2879

2019

Volltextzugriff (PDF)

CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus

Vaccine, 2009-11, Vol.27 (47), p.6558-6563

2009

Volltextzugriff (PDF)

Comprehensive evaluation of dietary tandem CpG oligodeoxynucleotides on enhancement of antioxidant capacity, immunological parameters, and intestinal microbiota in white shrimp (Litopenaeus vannamei)

Aquaculture, 2024-01, Vol.579, p.740250, Article 740250

2024

Volltextzugriff (PDF)

The immune enhancement effect of CpG-ODNs on the vaccine of inactivated Vibrio harveyi in tiger puffer (Takifugu rubripes)

Aquaculture, 2023-09, Vol.574, p.739634, Article 739634

2023

Volltextzugriff (PDF)

CpG ODN, Toll Like Receptor (TLR)-9 Agonist, Inhibits Metastatic Colon Adenocarcinoma in a Murine Hepatic Tumor Model

The Journal of surgical research, 2012-05, Vol.174 (2), p.284-290

2012

Volltextzugriff (PDF)

Trial Watch: Toll-like receptor agonists for cancer therapy

Oncoimmunology, 2013-08, Vol.2 (8), p.e25238-e25238

2013

Volltextzugriff (PDF)

Toll‐Like Receptor 9 Ligand Blocks Osteoclast Differentiation Through Induction of Phosphatase

Journal of bone and mineral research, 2007-08, Vol.22 (8), p.1301-1310

2007

Volltextzugriff (PDF)

Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade

Pharmacological research, 2020-11, Vol.161, p.105293-105293, Article 105293

2020

Volltextzugriff (PDF)

Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer

International journal of pharmaceutics, 2021-05, Vol.600, p.120504-120504, Article 120504

2021

Volltextzugriff (PDF)

1 – 25 von 512

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(467)
Mit Volltextzugriff
(473)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(448)
Life Sciences & Biomedicine
(421)
Animals
(330)
Immunology
(238)
Mice
(202)
Humans
(172)
Cpg Oligodeoxynucleotides
(142)
Oligodeoxynucleotides
(137)
Female
(132)
Cpg Islands
(109)
Oligodeoxyribonucleotides - Pharmacology
(107)
Biological And Medical Sciences
(106)
Cpg Oligodeoxynucleotide
(97)
Adjuvants, Immunologic - Pharmacology
(88)
Mice, Inbred Balb C
(82)
Cpg Islands - Immunology
(73)
Immune Response
(72)
Oligonucleotides
(69)
Oligodeoxyribonucleotides - Immunology
(65)
Cytokines
(62)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N -Acetyl-l-Leucine-Polyethyleneimine-Mediated Delivery of CpG Oligodeoxynucleotides 2006 Inhibits RAW264.7 Cell Osteoclastogenesis

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice

Expression of the transcribed ultraconserved region 70 and the related long non‐coding RNA AC092652.2‐202 has prognostic value in Chronic Lymphocytic Leukaemia

LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice

Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections

Phase I Trial of Wilms' Tumor 1 (WT1) Peptide Vaccine with GM-CSF or CpG in Patients with Solid Malignancy

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine

Oral priming with oligodeoxynucleotide particles from Lactobacillus rhamnosus GG attenuates symptoms of dextran sodium sulfate‐induced acute colitis in mice

Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate

Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides

IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN

Transcriptome and microRNAome elucidate the mechanism underlying the immunomodulatory effects of dietary CpG oligodeoxynucleotides (CpG ODNs) in Litopenaeus vannamei

Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN

Vascular bursts-mediated tumor accumulation and deep penetration of spherical nucleic acids for synergistic radio-immunotherapy

Nanoscale Zeolitic Imidazolate Framework‑8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides

An effective dendritic cell‐based vaccine containing glioma stem‐like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma

CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus

Comprehensive evaluation of dietary tandem CpG oligodeoxynucleotides on enhancement of antioxidant capacity, immunological parameters, and intestinal microbiota in white shrimp (Litopenaeus vannamei)

The immune enhancement effect of CpG-ODNs on the vaccine of inactivated Vibrio harveyi in tiger puffer (Takifugu rubripes)

CpG ODN, Toll Like Receptor (TLR)-9 Agonist, Inhibits Metastatic Colon Adenocarcinoma in a Murine Hepatic Tumor Model

Trial Watch: Toll-like receptor agonists for cancer therapy

Toll‐Like Receptor 9 Ligand Blocks Osteoclast Differentiation Through Induction of Phosphatase

Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade

Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer

Suchergebnisse filtern